- Tigem Research Highlights
-
Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors
-
Regulation of autophagosome biogenesis by OFD1-mediated selective autophagy
-
Beclin‐1‐mediated activation of autophagy improves proximal and distal urea cycle disorders
-
A pilot clinical trial with losartan in Myhre syndrome
-
Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B
-
MiT/TFE factors control ER ‐phagy via transcriptional regulation of FAM 134B
-
De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides-Baraitser syndrome
-
A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome
- Our Vision
-
TIGEM (Telethon Institute of Genetics and Medicine) is an international research institute dedicated to the discovery of the mechanisms underlying rare genetic diseases and the development of innovative therapies. Learn more >>
- Applications for European School of Molecular Medicine (SEMM) Phd Program are now open
-
Applications for the SMM PhD Program in Systems Medicine are now open. Check the call for application here
- Institutional Partnership
-
Tigem can count on an Institutional Partnership with the Department of Translational Medicine of the Federico II University of Naples
